BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26657500)

  • 1. MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis.
    Kindrat I; Tryndyak V; de Conti A; Shpyleva S; Mudalige TK; Kobets T; Erstenyuk AM; Beland FA; Pogribny IP
    Oncotarget; 2016 Jan; 7(2):1276-87. PubMed ID: 26657500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma.
    Babu KR; Muckenthaler MU
    Sci Rep; 2019 Feb; 9(1):1518. PubMed ID: 30728365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
    Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
    Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
    Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
    FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
    J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
    Zhang Q; Zhao S; Pang X; Chi B
    Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
    Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
    J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.
    Wang F; Xu WQ; Zhang WQ; Xu RC; Sun JL; Zhang GC; Liu ZY; Qi ZR; Dong L; Weng SQ; Shen XZ; Liu TT; Fang Y; Zhu JM
    Hepatol Int; 2024 Apr; 18(2):636-650. PubMed ID: 37982952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
    Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q
    Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.
    Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F
    Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X; Fan W; Chen Y
    Gene; 2018 May; 657():30-38. PubMed ID: 29505836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
    Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.